PTC Therapeutics

Duchenne muscular dystrophy
Motley Fool
Thu, 09/21/17 - 10:10 pm
Duchenne Muscular Dystrophy
PTC Therapeutics
Translarna
Axovant Sciences
Alzheimer's disease
NASH
Gilead Sciences
Key FDA Regulatory Events to Watch Out for in Sep 2017
Yahoo/Zacks.com
Mon, 09/4/17 - 10:31 pm
FDA
Mylan Labs
Herceptin
biosimilars
trastuzumab
Shingrix
GSK
Pfizer
Sutent
PTC Therapeutics
Translarna
Amgen
Allergan
Avastin
3 Biotech Stocks That Could Soar in September
Motley Fool
Sun, 08/27/17 - 06:26 pm
biotech
fitusiran
Alnylam
PTC Therapeutics
Translarna
Sarepta
Exondys 51
PTC and Roche report solid data for Spinraza rival
BioPharma Dive
Wed, 07/5/17 - 06:55 pm
PTC Therapeutics
Roche
Spinraza
Biogen
RG7916
SMA
spinal muscular atrophy
PTC to launch DMD drug with still high price tag
BioPharma Dive
Wed, 05/10/17 - 09:47 am
PTC Therapeutics
drug pricing
Duchenne Muscular Dystrophy
Emflaza
Payer snubs PTC's Emflaza, signaling pricing trouble ahead of launch
Fierce Pharma
Sat, 04/15/17 - 09:27 am
PTC Therapeutics
Emflaza
drug launches
drug pricing
Duchenne Muscular Dystrophy
PTC comes under fire from Congress for Emflaza
BioPharma Dive
Wed, 03/22/17 - 10:39 pm
PTC Therapeutics
Emflaza
drug pricing
congress
After being spurned at the FDA, PTC buys a controversial Duchenne MD therapy from Marathon
Endpoints
Thu, 03/16/17 - 09:48 am
FDA
PTC Therapeutics
Duchenne Muscular Dystrophy
Emflaza
Marathon Pharma
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle
TheStreet.com
Thu, 03/9/17 - 11:25 am
FDA
drug approvals
Alkermes
ALKS-5461
CytRx
aldoxorubicin
Dynavax Technologies
HEPLISAV-B
Intra-Cellular Therapies
ITI-007
Novan
SB204
Portola Pharmaceuticals
betrixaban
PTC Therapeutics
ataluren
Rigel Pharmaceuticals
fostamatinib
TG Therapeutics
ublituximab
Bad News Biotechs: What's Next for Juno and PTC Therapeutics?
Motley Fool
Mon, 03/6/17 - 09:40 am
Juno Therapeutics
PTC Therapeutics
CAR-T
Celgene
cystic fibrosis
Translarna
PTC shares plunge anew after FDA slaps down Duchenne drug for a second time
Endpoints
Mon, 10/17/16 - 11:46 pm
PTC Therapeutics
FDA
Duchenne Muscular Dystrophy
Translarna
Sarepta: The Competition Is At The Gate
Seeking Alpha
Fri, 08/12/16 - 09:53 am
Sarepta Therapeutics
eteplirsen
Biomarin
Summit Therapeutics
PTC Therapeutics
Duchenne Muscular Dystrophy
Duchenne drug rejected in US is available in England
Pharma Times
Fri, 07/8/16 - 10:16 am
Duchenne Muscular Dystrophy
England
PTC Therapeutics
Translarna
Biotech's Top 5 Stock Winners, And Losers, In Q1 2016
Forbes
Thu, 03/31/16 - 09:49 pm
biotech
PTC Therapeutics
Celldex Therapeutics
Biocryst
Puma Biotechnology
Portola Pharmaceuticals
MedicNova
BioTie Therapies
Editas Medicine
AveXis
Inovio
4 Biopharma and Pharmaceutical Stocks With Game-Changing Catalysts Coming
24/7 Wall St
Fri, 11/20/15 - 11:02 am
Pfizer
Sarepta Therapeutics
PTC Therapeutics
Amag Pharmaceuticals
PTC Therapeutics Drug Doesn't Meet Goal in Duchenne Trial
Bloomberg
Fri, 10/16/15 - 06:59 am
PTC Therapeutics
Duchenne Muscular Dystrophy
clinical trials
Translarna
FDA finally responds to demand for Duchenne Muscular Dystrophy guidance
BioPharma Dive
Wed, 06/10/15 - 10:58 am
FDA
Duchenne Muscular Dystrophy
Saretpa
PTC Therapeutics
Pfizer
Biomarin
Roche presses pause on PTC's SMA drug over a safety scare
Fierce Biotech
Tue, 05/5/15 - 11:06 am
Roche
PTC Therapeutics
spinal muscular atrophy
RG7800
It's A Big Weekend For Biotech
Yahoo/Benzinga
Sat, 04/18/15 - 11:55 am
biotech
Biogen
BIIB037
RG7800
PTC Therapeutics
Alnylam
CAR-T
Merck
Bristol-Myers Squibb
Novartis
Juno Therapeutics
Bellicum
This biotech doubled in value last year
CNBC
Mon, 01/19/15 - 10:08 am
PTC Therapeutics
Shire

Pages